Swedish researchers have made a step forward in diabetes research which could help to reverse type 2 diabetes.
The researchers studied the effects of an antibody named 2H10 which blocks the action of a fat storage protein, VEGF-B (vascular endothelial growth factor B), which has been shown to play a role in the uptake of fatty acid by blood vessels. The researchers, from Sweden’s, Karolinska Institutet, set out to stop VEGF-B from depositing fat in the wrong places such as in muscles and other organs.
The study examined mice which were fed a high fat diet designed to bring on insulin resistance and type 2 diabetes. The mice that were given the drug candidate, 2H10, were able to reverse the effects of type 2 diabetes. The research team also found that taking the drug could also prevent insulin resistance and type 2 diabetes from developing in the mice.
The human body contains a vast array of proteins which interact with each other to form a network of communication that helps each part of the body to function correctly. In a healthy body, each protein has beneficial effects. The research shows that blocking VEGF-B protein helps to reverse diabetes, but more research will be needed to show whether any side effects result from blocking this protein.
The study, titled ‘Targeting VEGF-B as a novel treatment for insulin resistance and type 2 diabetes’ is published in September’s issue of the Nature journal.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.

You May Also Like

Top diabetes professor drafts risk assessment document for frontline COVID-19 staff

The health and wellbeing of frontline NHS staff has been prioritised among…

Conversation about doctors’ appointments occurring virtually rumbles on

More than half of GP appointments are still being delivered remotely in…

Coronavirus: UK instructed to stay at home this weekend

Health Secretary Matt Hancock has said that staying at home this weekend…